$NB
NIOCORP DEVELOPMENTS LTD Stock $nb

$nb Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000153949724000937 Filed on May 02, 2024

Income Statement

Concept	2024 Q2	2024 Q1
Revenue	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$1.089M	$3.164M
YoY Change	-53.26%	102.56%
% of Gross Profit
Research & Development	$135.0K	$489.0K
YoY Change	-89.85%	-65.32%
% of Gross Profit
Depreciation & Amortization	$0.00	$1.000K
YoY Change		0.0%
% of Gross Profit
Operating Expenses	$2.287M	$5.110M
YoY Change	-41.95%	-82.5%
Operating Profit
YoY Change
Interest Expense	$1.398M	$1.016M
YoY Change	-286.4%	615.49%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$937.0K	-$4.225M
YoY Change	-80.02%	-85.74%
Income Tax	-$38.00K
% Of Pretax Income
Net Earnings	-$875.0K	-$4.225M
YoY Change	-80.25%	-85.6%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share	-$0.02	-$0.12
COMMON SHARES
Basic Shares Outstanding	36.48M shares	34.92M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2024 Q2	2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.012M	$194.0K
YoY Change	-14.02%	-97.28%
Cash & Equivalents	$2.012M	$194.0K
Short-Term Investments
Other Short-Term Assets	$916.0K	$261.0K
YoY Change	-34.1%	171.88%
Inventory
Prepaid Expenses	$916.0K
Receivables
Other Receivables
Total Short-Term Assets	$2.928M	$455.0K
YoY Change	-21.42%	-93.72%
LONG-TERM ASSETS
Property, Plant & Equipment	$837.0K	$17.12M
YoY Change	-0.24%	-0.33%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$4.000K	$7.000K
YoY Change	-60.0%	0.0%
Other Assets	$35.00K	$35.00K
YoY Change	-12.5%	0.0%
Total Long-Term Assets	$17.14M	$17.16M
YoY Change	-0.36%	-0.33%
TOTAL ASSETS
Total Short-Term Assets	$2.928M	$455.0K
Total Long-Term Assets	$17.14M	$17.16M
Total Assets	$20.07M	$17.61M
YoY Change	-4.11%	-27.98%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.843M	$5.127M
YoY Change	-47.21%	149.49%
Accrued Expenses	$522.0K	$434.0K
YoY Change	107.14%	191.28%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change		-100.0%
Long-Term Debt Due	$7.660M	$1.707M
YoY Change
Total Short-Term Liabilities	$11.96M	$9.133M
YoY Change	235.88%	95.23%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change	-100.0%	-100.0%
Other Long-Term Liabilities	$1.651M	$2.216M
YoY Change	-66.91%	-58.21%
Total Long-Term Liabilities	$1.651M	$2.216M
YoY Change	-66.91%	-58.21%
TOTAL LIABILITIES
Total Short-Term Liabilities	$11.96M	$9.133M
Total Long-Term Liabilities	$1.651M	$2.216M
Total Liabilities	$17.54M	$18.14M
YoY Change	-41.15%	-47.79%
SHAREHOLDERS EQUITY
Retained Earnings	-$161.9M	-$161.0M
YoY Change	7.6%	10.26%
Common Stock	$163.8M	$159.9M
YoY Change	16.67%	18.9%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.000M	-$2.094M
YoY Change
Total Liabilities & Shareholders Equity	$20.07M	$17.61M
YoY Change	-4.11%	-27.98%

Cashflow Statement

Concept	2024 Q2	2024 Q1
OPERATING ACTIVITIES
Net Income	-$875.0K	-$4.225M
YoY Change	-80.25%	-85.6%
Depreciation, Depletion And Amortization	$0.00	$1.000K
YoY Change		0.0%
Cash From Operating Activities	-$6.116M	-$991.0K
YoY Change	4.91%	-86.5%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities		$0.00
YoY Change
Cash From Investing Activities		$0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	7.934M	551.0K
YoY Change	677.84%	-96.11%
NET CHANGE
Cash From Operating Activities	-6.116M	-991.0K
Cash From Investing Activities		0.000
Cash From Financing Activities	7.934M	551.0K
Net Change In Cash	1.818M	-440.0K
YoY Change	-137.8%	-106.44%
FREE CASH FLOW
Cash From Operating Activities	-$6.116M	-$991.0K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		usd
CY2023Q2	us-gaap	Convertible Debt Current ConvertibleDebtCurrent		usd
CY2023Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent		usd
CY2024Q1	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent		usd
	us-gaap	Common Stock Shares Authorized Unlimited CommonStockSharesAuthorizedUnlimited	Unlimited
CY2023	us-gaap	Common Stock Shares Authorized Unlimited CommonStockSharesAuthorizedUnlimited	Unlimited
CY2024Q1	us-gaap	Extinguishment Of Debt Amount ExtinguishmentOfDebtAmount		usd
	us-gaap	Extinguishment Of Debt Amount ExtinguishmentOfDebtAmount		usd
CY2024Q1	us-gaap	Other Income OtherIncome		usd
CY2023Q1	niobf	Other Gain OtherGain		usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2024Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax		usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax		usd
	niobf	Assumption Of Earnout Liability AssumptionOfEarnoutLiability		usd
	niobf	Losses On Extinguishment Of Debt LossesOnExtinguishmentOfDebt		usd
	niobf	Loss On Equity Facility Shares Issued LossOnEquityFacilitySharesIssued		usd
	niobf	Private Placement Compensation Adjustment PrivatePlacementCompensationAdjustment		usd
	niobf	Fair Value Of Commitment Shares Issued FairValueOfCommitmentSharesIssued		usd
	niobf	Foreign Currency Transaction Gain Loss Before Tax1 ForeignCurrencyTransactionGainLossBeforeTax1		usd
	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets		usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt		usd
	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts		usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		usd
CY2023Q1	niobf	Common Shares Issued In The Gxii Transaction CommonSharesIssuedInTheGXIITransaction		usd
	niobf	Common Shares Issued In The Gxii Transaction CommonSharesIssuedInTheGXIITransaction		usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		usd
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1
CY2024Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-169000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-92000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-439000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-92000	usd
CY2024Q1	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent		usd
	niobf	Class Of Warrant Or Right Exercised ClassOfWarrantOrRightExercised		shares
	niobf	Class Of Warrant Or Right Exercise Price Exercised ClassOfWarrantOrRightExercisePriceExercised
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	261000	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1385000	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	455000	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	3726000	usd
CY2024Q1	us-gaap	Deposits Assets DepositsAssets	35000	usd
CY2023Q2	us-gaap	Deposits Assets DepositsAssets	35000	usd
CY2024Q1	us-gaap	Long Term Investments And Receivables Net LongTermInvestmentsAndReceivablesNet	7000	usd
CY2023Q2	us-gaap	Long Term Investments And Receivables Net LongTermInvestmentsAndReceivablesNet	9000	usd
CY2024Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	195000	usd
CY2023Q2	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	236000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	837000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	839000	usd
CY2024Q1	us-gaap	Capitalized Costs Mineral Interests In Unproved Properties CapitalizedCostsMineralInterestsInUnprovedProperties	16085000	usd
CY2023Q2	us-gaap	Capitalized Costs Mineral Interests In Unproved Properties CapitalizedCostsMineralInterestsInUnprovedProperties	16085000	usd
CY2024Q1	us-gaap	Assets Assets	17614000	usd
CY2023Q2	us-gaap	Assets Assets	20930000	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	5127000	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	3491000	usd
CY2024Q1	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	1707000	usd
CY2024Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2193000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	95000	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	71000	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	9133000	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	3562000	usd
CY2023Q2	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	10561000	usd
CY2024Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2216000	usd
CY2023Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	4989000	usd
CY2024Q1	niobf	Earnout Liability At Fair Value EarnoutLiabilityAtFairValue	6667000	usd
CY2023Q2	niobf	Earnout Liability At Fair Value EarnoutLiabilityAtFairValue	10521000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	120000	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	164000	usd
CY2024Q1	us-gaap	Liabilities Liabilities	18136000	usd
CY2023Q2	us-gaap	Liabilities Liabilities	29797000	usd
CY2024Q1	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	1572000	usd
CY2023Q2	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	2100000	usd
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	36252990	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	31202131	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	159854000	usd
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	140421000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-161037000	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-150477000	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-911000	usd
CY2023Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-911000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-2094000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-10967000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	17614000	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	20930000	usd
CY2024Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	2531000	usd
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	1989000	usd
CY2023Q1	us-gaap	Professional Fees ProfessionalFees	157000	usd
	us-gaap	Professional Fees ProfessionalFees	2772000	usd
CY2024Q1	niobf	Exploration Expenditures ExplorationExpenditures	489000	usd
	niobf	Exploration Expenditures ExplorationExpenditures	4015000	usd
CY2023Q1	us-gaap	Other General Expense OtherGeneralExpense	26220000	usd
	us-gaap	Other General Expense OtherGeneralExpense	3100000	usd
	us-gaap	Other General Expense OtherGeneralExpense	26888000	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	5110000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	29192000	usd
	us-gaap	Operating Expenses OperatingExpenses	11470000	usd
	us-gaap	Operating Expenses OperatingExpenses	33475000	usd
CY2024Q1	niobf	Change In Fair Value Of Earnout Liability ChangeInFairValueOfEarnoutLiability	955000	usd
CY2023Q1	niobf	Change In Fair Value Of Earnout Liability ChangeInFairValueOfEarnoutLiability	881000	usd
	niobf	Change In Fair Value Of Earnout Liability ChangeInFairValueOfEarnoutLiability	3854000	usd
	niobf	Change In Fair Value Of Earnout Liability ChangeInFairValueOfEarnoutLiability	881000	usd
CY2024Q1	niobf	Change In Fair Value Of Warrant Liability ChangeInFairValueOfWarrantLiability	724000	usd
CY2023Q1	niobf	Change In Fair Value Of Warrant Liability ChangeInFairValueOfWarrantLiability	-784000	usd
	niobf	Change In Fair Value Of Warrant Liability ChangeInFairValueOfWarrantLiability	580000	usd
	niobf	Change In Fair Value Of Warrant Liability ChangeInFairValueOfWarrantLiability	-868000	usd
CY2023Q1	us-gaap	Extinguishment Of Debt Amount ExtinguishmentOfDebtAmount	300000	usd
	us-gaap	Extinguishment Of Debt Amount ExtinguishmentOfDebtAmount	1922000	usd
CY2024Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	27000	usd
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-83000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	10000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-192000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	1016000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	142000	usd
	us-gaap	Interest Expense InterestExpense	4267000	usd
	us-gaap	Interest Expense InterestExpense	362000	usd
CY2023Q1	us-gaap	Other Income OtherIncome	-1000	usd
	us-gaap	Other Income OtherIncome	-2000	usd
	us-gaap	Other Income OtherIncome	-2000	usd
CY2024Q1	niobf	Other Gain OtherGain	195000	usd
	niobf	Other Gain OtherGain	195000	usd
	niobf	Other Gain OtherGain	13000	usd
CY2024Q1	niobf	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest1 IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1	-4225000	usd
CY2023Q1	niobf	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest1 IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1	-29621000	usd
	niobf	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest1 IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1	-11100000	usd
	niobf	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest1 IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest1	-35927000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-186000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-101000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-186000	usd
CY2024Q1	niobf	Profit Loss1 ProfitLoss1	-4225000	usd
CY2023Q1	niobf	Profit Loss1 ProfitLoss1	-29435000	usd
	niobf	Profit Loss1 ProfitLoss1	-10999000	usd
	niobf	Profit Loss1 ProfitLoss1	-35741000	usd
CY2024Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-169000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-92000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-439000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-92000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-4056000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-29343000	usd
	us-gaap	Profit Loss ProfitLoss	-10560000	usd
	us-gaap	Profit Loss ProfitLoss	-35649000	usd
CY2024Q1	niobf	Profit Loss1 ProfitLoss1	-4225000	usd
CY2023Q1	niobf	Profit Loss1 ProfitLoss1	-29435000	usd
	niobf	Profit Loss1 ProfitLoss1	-10999000	usd
	niobf	Profit Loss1 ProfitLoss1	-35741000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-112000	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-82000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4225000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-29323000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-10999000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-35659000	usd
CY2024Q1	us-gaap	Oci Equity Method Investment Before Tax Noncontrolling Interest OciEquityMethodInvestmentBeforeTaxNoncontrollingInterest	169000	usd
CY2023Q1	us-gaap	Oci Equity Method Investment Before Tax Noncontrolling Interest OciEquityMethodInvestmentBeforeTaxNoncontrollingInterest	92000	usd
	us-gaap	Oci Equity Method Investment Before Tax Noncontrolling Interest OciEquityMethodInvestmentBeforeTaxNoncontrollingInterest	439000	usd
	us-gaap	Oci Equity Method Investment Before Tax Noncontrolling Interest OciEquityMethodInvestmentBeforeTaxNoncontrollingInterest	92000	usd
CY2024Q1	us-gaap	Oci Equity Method Investment Before Tax Parent OciEquityMethodInvestmentBeforeTaxParent	-4056000	usd
CY2023Q1	us-gaap	Oci Equity Method Investment Before Tax Parent OciEquityMethodInvestmentBeforeTaxParent	-29231000	usd
	us-gaap	Oci Equity Method Investment Before Tax Parent OciEquityMethodInvestmentBeforeTaxParent	-10560000	usd
	us-gaap	Oci Equity Method Investment Before Tax Parent OciEquityMethodInvestmentBeforeTaxParent	-35567000	usd
CY2024Q1	niobf	Earnings Loss Per Share Basic And Diluted EarningsLossPerShareBasicAndDiluted	0.11
CY2023Q1	niobf	Earnings Loss Per Share Basic And Diluted EarningsLossPerShareBasicAndDiluted	1.00
	niobf	Earnings Loss Per Share Basic And Diluted EarningsLossPerShareBasicAndDiluted	0.29
	niobf	Earnings Loss Per Share Basic And Diluted EarningsLossPerShareBasicAndDiluted	1.26
CY2024Q1	niobf	Total Weighted Average Number Of Share Outstanding Basic And Diluted TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted	35160333	shares
CY2023Q1	niobf	Total Weighted Average Number Of Share Outstanding Basic And Diluted TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted	28546379	shares
	niobf	Total Weighted Average Number Of Share Outstanding Basic And Diluted TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted	33421185	shares
	niobf	Total Weighted Average Number Of Share Outstanding Basic And Diluted TotalWeightedAverageNumberOfShareOutstandingBasicAndDiluted	28128731	shares
	us-gaap	Net Income Loss NetIncomeLoss	-10999000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-35741000	usd
	niobf	Assumption Of Earnout Liability AssumptionOfEarnoutLiability	13195000	usd
	niobf	Change In Fair Value Of Earnout Share Liability ChangeInFairValueOfEarnoutShareLiability	-3854000	usd
	niobf	Change In Fair Value Of Earnout Share Liability ChangeInFairValueOfEarnoutShareLiability	-881000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	3848000	usd
	niobf	Assumption Of Private And Public Warrants AssumptionOfPrivateAndPublicWarrants	-580000	usd
	niobf	Assumption Of Private And Public Warrants AssumptionOfPrivateAndPublicWarrants	868000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	2779000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1788000	usd
	us-gaap	Accretion Expense AccretionExpense	4267000	usd
	us-gaap	Accretion Expense AccretionExpense	215000	usd
	niobf	Losses On Extinguishment Of Debt LossesOnExtinguishmentOfDebt	1422000	usd
	niobf	Loss On Equity Facility Shares Issued LossOnEquityFacilitySharesIssued	78000	usd
	niobf	Private Placement Compensation Adjustment PrivatePlacementCompensationAdjustment	102000	usd
	niobf	Fair Value Of Commitment Shares Issued FairValueOfCommitmentSharesIssued	650000	usd
	niobf	Foreign Currency Transaction Gain Loss Before Tax1 ForeignCurrencyTransactionGainLossBeforeTax1	200000	usd
	niobf	Otheroperating Gains Losses OtheroperatingGainsLosses	195000	usd
	niobf	Otheroperating Gains Losses OtheroperatingGainsLosses	13000	usd
	us-gaap	Depreciation Depreciation	2000	usd
	us-gaap	Depreciation Depreciation	2000	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-2000	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-2000	usd
	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	21000	usd
	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	-12000	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-1124000	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-304000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1637000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2688000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5616000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-11465000	usd
	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	21000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	21000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	3663000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	11000	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	194000	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	21000	usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt	515000	usd
	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	14857000	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	1130000	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	1841000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3469000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	13621000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-312000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2147000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1865000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2341000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5280000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	194000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7145000	usd
	us-gaap	Interest Paid Net InterestPaidNet	239000	usd
	niobf	Conversions Of Debt For Common Shares ConversionsOfDebtForCommonShares	13121000	usd
	niobf	Conversions Of Debt For Common Shares ConversionsOfDebtForCommonShares	1950000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	13269000	usd
CY2023Q1	niobf	Stock Issued During Period Value Issuance Of Financing Warrants StockIssuedDuringPeriodValueIssuanceOfFinancingWarrants	3337000	usd
CY2023Q1	niobf	Redeemable Noncontrolling Interest RedeemableNoncontrollingInterest	-2325000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	650000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	1788000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	112000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-29343000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-12512000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-6082000	usd
CY2024Q1	niobf	Shares Issued Under The Yorkville Equity Facility SharesIssuedUnderTheYorkvilleEquityFacility	622000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments	4815000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	-55000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Stock Dividend StockIssuedDuringPeriodValueStockDividend	206000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	89000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	2779000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-4056000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-2094000	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	17665000	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	11000	usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments	1950000	usd
	niobf	Stock Issued During Period Value Issuance Of Financing Warrants StockIssuedDuringPeriodValueIssuanceOfFinancingWarrants	3337000	usd
	niobf	Redeemable Noncontrolling Interest RedeemableNoncontrollingInterest	-2325000	usd
	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	650000	usd
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	1788000	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	-21000	usd
	niobf	Stock Issued During Period Value Foreign Currency Translation Adjustment StockIssuedDuringPeriodValueForeignCurrencyTranslationAdjustment	82000	usd
	us-gaap	Profit Loss ProfitLoss	-35649000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-12512000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-10967000	usd
	niobf	Private Placement Shares May2021 PrivatePlacementSharesMay2021	2393000	usd
	niobf	Shares Issued Under The Yorkville Equity Facility SharesIssuedUnderTheYorkvilleEquityFacility	1451000	usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments	13121000	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	-194000	usd
	us-gaap	Stock Issued During Period Value Stock Dividend StockIssuedDuringPeriodValueStockDividend	206000	usd
	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	89000	usd
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	2779000	usd
	us-gaap	Profit Loss ProfitLoss	-10560000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-2094000	usd
	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_80F_eus-gaap--NatureOfOperations_zZgoihsNe3Pe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"><span style="font-size: 10pt">1.</span></td> <td style="text-align: justify"><span style="font-size: 10pt"><span id="xdx_821_zaBY4G2UZW7b">DESCRIPTION OF BUSINESS</span></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">NioCorp Developments Ltd. (“we,” “us,” “our,” “NioCorp” or the “Company”) was incorporated on February 27, 1987, under the laws of the Province of British Columbia and currently operates in <span id="xdx_90A_eus-gaap--NumberOfReportableSegments_dxL_uNumber_c20230701__20240331_zTRPpfHTC0f6" title="Number of reportable segments::XDX::1"><span style="-sec-ix-hidden: xdx2ixbrl0713">one</span></span> reportable operating segment consisting of exploration and development of mineral deposits in North America, specifically, the Elk Creek development-stage property (the “Elk Creek Project”) located in southeastern Nebraska.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">In October 2023, NioCorp Technologies Ltd. (“Technologies”), a wholly owned subsidiary of the Company, was incorporated in the United Kingdom (the “UK”). The initial capital contribution in Technologies was £100 for 100 ordinary shares. Technologies was formed to provide the ability to take advantage of various business opportunities in the UK, including research and development of aluminum-scandium alloys.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">These interim condensed consolidated financial statements have been prepared on a going concern basis that contemplates the realization of assets and discharge of liabilities at their carrying values in the normal course of business for the foreseeable future. These financial statements do not reflect any adjustments that may be necessary if the Company is unable to continue as a going concern.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The Company currently earns no operating revenues and will require additional capital in order to advance the Elk Creek Project to construction and commercial operation. As further discussed in Note 3, these matters raised substantial doubt about the Company’s ability to continue as a going concern, and the Company is dependent upon the generation of profits from mineral properties, obtaining additional financing and maintaining continued support from its shareholders and creditors. </p>
	us-gaap	Basis Of Accounting BasisOfAccounting	<p id="xdx_804_eus-gaap--BasisOfAccounting_zsoQ7wjapN77" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; width: 100%"><tr style="vertical-align: top"> <td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">2.</span></td><td><span style="font-size: 10pt"><span id="xdx_82A_zGBwEJcDX28e">BASIS OF PRESENTATION</span></span></td> </tr></table> <p id="xdx_848_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_znRvOjC4v4t9" style="margin-top: 0; margin-bottom: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; width: 100%"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">a)</span></td><td><span style="font-size: 10pt"><span id="xdx_865_zQSVk30vHXxc">Basis of Presentation and Consolidation</span></span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The accompanying interim condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles of the United States of America (“U.S. GAAP”) and the rules and regulations of the Securities and Exchange Commission (“SEC”). The interim condensed consolidated financial statements include the consolidated accounts of the Company and its wholly owned subsidiaries with all significant intercompany transactions eliminated. The accounting policies followed in preparing these interim condensed consolidated financial statements are those used by the Company as set out in the audited consolidated financial statements for the year ended June 30, 2023. Certain transactions include reference to Canadian dollars (“C$”) where applicable.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In the opinion of management, all adjustments considered necessary (including normal recurring adjustments) for a fair statement of the financial position, results of operations, and cash flows at March 31, 2024, and for all periods presented, have been included in these interim condensed consolidated financial statements. Certain information and footnote disclosures normally included in the consolidated financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to appropriate SEC rules and regulations. These interim condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements for the year ended June 30, 2023. The interim results are not necessarily indicative of results for the full year ending June 30, 2024, or future operating periods.</p> <p id="xdx_856_z9wijKMiTrO" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p id="xdx_844_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zEusO3m91by6" style="margin-top: 0; margin-bottom: 0"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; width: 100%"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">b)</span></td><td><span style="font-size: 10pt"><span id="xdx_86D_zL7YStw0c1G9">Recent Accounting Standards</span></span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="text-decoration: underline">Issued and Not Effective</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In October 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-06, <i>Disclosure Improvements - Codification Amendment in Response to the SEC’s Disclosure Update and Simplification Initiative</i>. The amendments in this update modify the disclosure or presentation requirements of a variety of Topics in the Accounting Standards Codification (“ASC”) in response to the</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">SEC’s Release No. 33-10532, <i>Disclosure Update and Simplification Initiative</i>, and align the ASC’s requirements with the SEC’s regulations. For entities subject to the SEC’s existing disclosure requirements, the effective date for each amendment will be the date on which the SEC’s removal of that related disclosure from Regulation S-X or Regulation S-K becomes effective. However, if by June 30, 2027, the SEC has not removed the related disclosure from its regulations, the amendments will be removed from the ASC and not become effective. Early adoption is prohibited. We are currently in the process of evaluating the impact of the amendment on our consolidated financial statements and related disclosures.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In November 2023, the FASB issued ASU 2023-07, <i>Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures</i>, which is intended to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant expenses. The amendments will require public entities to disclose significant segment expenses that are regularly provided to the chief operating decision maker and included within segment profit and loss. The amendments are effective for the Company’s annual periods beginning July 1, 2024, and interim periods beginning July 1, 2025, with early adoption permitted, and will be applied retrospectively to all prior periods presented in the financial statements. The Company is currently evaluating the ASU to determine its impact on the Company’s disclosures.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In December 2023, the FASB issued ASU 2023-09, <i>Income Taxes (Topic 740): Improvements to Income Tax Disclosures</i>, which includes amendments that further enhance income tax disclosures, primarily through standardization and disaggregation of rate reconciliation categories and income taxes paid by jurisdiction. The amendments are effective for the Company’s annual periods beginning June 1, 2025, with early adoption permitted, and should be applied either prospectively or retrospectively. The Company is currently evaluating the ASU to determine its impact on the Company’s disclosures.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In March 2024, the SEC issued final rules on the enhancement and standardization of climate-related disclosures. The rules require disclosure of, among other things: material climate-related risks; activities to mitigate or adapt to such risks; governance and management of such risks; and material greenhouse gas emissions from operations owned or controlled (Scope 1) and/or indirect emissions from purchased energy consumed in operations (Scope 2). Additionally, the rules require disclosure in the notes to the financial statements of the effects of severe weather events and other natural conditions, subject to certain materiality thresholds. As a smaller reporting company, the rules will become effective on a phased-in timeline starting in fiscal years beginning in calendar year 2027, which for us is fiscal 2028. On April 4, 2024, the SEC issued an order staying the rules during the pendency of the various challenges to the rules’ validity. We are in the process of analyzing the impact of the rules on our disclosures.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">From time to time, new accounting pronouncements are issued by the FASB that are adopted by the Company as of the specified effective date. Unless otherwise discussed, management believes that the impact of recently issued standards did not or will not have a material impact on the Company’s consolidated financial statements upon adoption.</p> <p id="xdx_85D_zAMZ92xL6Ztb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p id="xdx_847_eus-gaap--UseOfEstimates_zpqYF51i4lci" style="margin-top: 0; margin-bottom: 0"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; width: 100%"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">c)</span></td><td><span style="font-size: 10pt"><span id="xdx_86E_zncxrOQRZSC8">Use of Estimates</span></span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to the carrying value of long-term assets, deferred income tax assets and related valuations, liabilities related to the Earnout Shares, Private Warrants, and Contingent Consent Warrants (each, as defined below), and share-based compensation. The Company bases its estimates and assumptions on current facts, historical experience, and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between estimates and the actual results, future results of operations will be affected.</p> <p id="xdx_851_z49JBYIsm3Of" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p> <p id="xdx_847_eus-gaap--EarningsPerSharePolicyTextBlock_zCjFraSymXJ3" style="margin-top: 0; margin-bottom: 0"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; width: 100%"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">d)</span></td><td><span style="font-size: 10pt"><span><span id="xdx_86D_zz6H8ne21Y6i">Basic and Diluted Earnings per Share</span></span></span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p id="xdx_893_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zHzDDi9KIDY2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company utilizes the weighted average method to determine the impact of changes in a participating security on the calculation of loss per share. <span id="xdx_8BE_zlE0Ss4DYP3">The following table sets forth the computation of the Company’s basic and diluted net loss per share attributable to common shareholders:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify; padding-left: 0.125in; text-indent: -0.125in"> </td><td> </td> <td colspan="6" style="text-align: center">For the Three Months Ended <br/> March 31,</td><td> </td><td> </td> <td colspan="6" style="text-align: center">For the Nine Months Ended <br/> March 31,</td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify; padding-left: 0.125in; text-indent: -0.125in"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2023</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; text-align: justify; padding-left: 0.25in; text-indent: -0.125in">Net loss</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--NetIncomeLoss_iN_pn3n3_di_c20240101__20240331_zFH6eHDPeKuf" style="width: 9%; text-align: right" title="Net loss">4,225</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--NetIncomeLoss_iN_pn3n3_di_c20230101__20230331_zcQQhXT4hQV6" style="width: 9%; text-align: right" title="Net loss">29,435</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--NetIncomeLoss_iN_pn3n3_di_c20230701__20240331_zyhwjbOWbVP2" style="width: 9%; text-align: right" title="Net loss">10,999</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--NetIncomeLoss_iN_pn3n3_di_c20220701__20230331_zu2V9RGlrVi9" style="width: 9%; text-align: right" title="Net loss">35,741</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in">Adjust: Net loss attributable to noncontrolling interest</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pn3n3_dxL_c20240101__20240331_zMvYENxCcalc" style="border-bottom: Black 1pt solid; text-align: right" title="Adjust: net loss attributable to noncontrolling interest::XDX::-169"><span style="-sec-ix-hidden: xdx2ixbrl0746">(167</span></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pn3n3_dxL_c20230101__20230331_z0rKdAOHqxal" style="border-bottom: Black 1pt solid; text-align: right" title="Adjust: net loss attributable to noncontrolling interest::XDX::-92"><span style="-sec-ix-hidden: xdx2ixbrl0748">(56</span></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pn3n3_dxL_c20230701__20240331_z3J9YHjWwDj5" style="border-bottom: Black 1pt solid; text-align: right" title="Adjust: net loss attributable to noncontrolling interest::XDX::-439"><span style="-sec-ix-hidden: xdx2ixbrl0750">(520</span></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pn3n3_dxL_c20220701__20230331_zOcOPMw8UeZi" style="border-bottom: Black 1pt solid; text-align: right" title="Adjust: net loss attributable to noncontrolling interest::XDX::-92"><span style="-sec-ix-hidden: xdx2ixbrl0752">(43</span></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-left: 0.25in; text-indent: -0.125in">Net loss available to participating securities</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pn3n3_c20240101__20240331_zWZ2yrGQ3r82" style="text-align: right" title="Net loss available to participating securities">4,058</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pn3n3_c20230101__20230331_zU8UHtrzaLwj" style="text-align: right" title="Net loss available to participating securities">29,379</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pn3n3_c20230701__20240331_zScTDh0OeVw3" style="text-align: right" title="Net loss available to participating securities">10,479</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_pn3n3_c20220701__20230331_zaQVMFPy9Te9" style="text-align: right" title="Net loss available to participating securities">35,698</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in">Net loss attributable to vested shares of ECRC Class B common stock</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_pn3n3_c20240101__20240331_zh2tZGFIEA7e" style="border-bottom: Black 1pt solid; text-align: right" title="Net loss attributable to vested shares of ECRC Class B common stock">(184</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_pn3n3_c20230101__20230331_zAePf7Jw6uOg" style="border-bottom: Black 1pt solid; text-align: right" title="Net loss attributable to vested shares of ECRC Class B common stock">(708</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_pn3n3_c20230701__20240331_zHRh5kkU6qO8" style="border-bottom: Black 1pt solid; text-align: right" title="Net loss attributable to vested shares of ECRC Class B common stock">(825</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_pn3n3_c20220701__20230331_z1nf5lHq4WUc" style="border-bottom: Black 1pt solid; text-align: right" title="Net loss attributable to vested shares of ECRC Class B common stock">(271</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in">Net loss attributed to common shareholders - basic and diluted</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98F_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_pn3n3_c20240101__20240331_zLOtl2xy8Oyj" style="border-bottom: Black 2pt solid; text-align: right" title="Net loss attributable to vested shares of ECRC Class B common stock">3,874</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98F_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_pn3n3_c20230101__20230331_zyEBkM6Oejdk" style="border-bottom: Black 2pt solid; text-align: right" title="Net loss attributed to common shareholders - basic and diluted">28,671</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98B_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_pn3n3_c20230701__20240331_z5qoIliuUuGb" style="border-bottom: Black 2pt solid; text-align: right" title="Net loss attributed to common shareholders - basic and diluted">9,654</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98A_eus-gaap--NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_pn3n3_c20220701__20230331_zIYofP2sekAe" style="border-bottom: Black 2pt solid; text-align: right" title="Net loss attributed to common shareholders - basic and diluted">35,427</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-left: 0.125in; text-indent: -0.125in">Denominator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-left: 0.25in; text-indent: -0.125in">Weighted average shares outstanding – basic and diluted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_uShares_c20240101__20240331_zuuO04g0gBB6" style="text-align: right" title="Weighted average shares outstanding basic and diluted">35,160,333</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_uShares_c20230101__20230331_z7d7hWEI4QR5" style="text-align: right" title="Weighted average shares outstanding basic and diluted">28,546,379</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_uShares_c20230701__20240331_zzQqkfvueEu1" style="text-align: right" title="Weighted average shares outstanding basic and diluted">33,421,185</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_uShares_c20220701__20230331_zkAhhLXDIwEj" style="text-align: right" title="Weighted average shares outstanding basic and diluted">28,128,731</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.125in; text-indent: -0.125in"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1pt; padding-left: 0.25in; text-indent: -0.125in">Loss per Common Share outstanding – basic and diluted</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_984_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20240101__20240331_zyjdtahCezxh" style="border-bottom: Black 2pt solid; text-align: right" title="Loss per common share outstanding basic and diluted">0.11</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98C_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20230101__20230331_zu1gRQyEW57e" style="border-bottom: Black 2pt solid; text-align: right" title="Loss per common share outstanding basic and diluted">1.00</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_985_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20230701__20240331_zhU4I8hpUMhf" style="border-bottom: Black 2pt solid; text-align: right" title="Loss per common share outstanding basic and diluted">0.29</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 2pt solid; text-align: left">$</td><td id="xdx_98E_ecustom--EarningsLossPerShareBasicAndDiluted_pid_uUSDPShares_c20220701__20230331_zlMKF5dsC0yf" style="border-bottom: Black 2pt solid; text-align: right" title="Loss per common share outstanding basic and diluted">1.26</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> </table> <p id="xdx_8A4_zDHkvFSrpE89" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The following common shares, no par value, of the Company (“Common Shares”) underlying options to purchase Common Shares (“Options”), Common Share purchase warrants (“Warrants”), and outstanding convertible debt were antidilutive due to a net loss in the periods presented and, therefore, were excluded from the dilutive securities computation for the three- and nine-month periods indicated below.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p id="xdx_89B_eus-gaap--ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock_zOyuuKyFogs6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span id="xdx_8B2_zXj749zM32T3" style="display: none; visibility: hidden">Schedule of excluded from the dilutive securities</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="text-align: right"> </td><td> </td> <td colspan="6" style="text-align: center">For the Three and Nine Months Ended <br/> March 31,</td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid">Excluded potentially dilutive securities <sup id="xdx_F63_zn5kmGwQO0zj">(1)(2)</sup>:</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2024</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">2023</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 50%">Options</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_988_eus-gaap--IncrementalCommonSharesAttributableToWrittenPutOptions_pid_uShares_c20240101__20240331_fKDEpKDIp_zdluahk4oTO9" style="width: 12%; text-align: right" title="Options">2,563,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--IncrementalCommonSharesAttributableToWrittenPutOptions_pid_uShares_c20220701__20230331_fKDEpKDIp_z672jdIRHPqh" style="width: 12%; text-align: right" title="Options">1,561,500</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Warrants</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_pid_uShares_c20240101__20240331_fKDEpKDIp_z0sYtTb2Odbb" style="text-align: right" title="Warrants">18,585,105</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_pid_uShares_c20220701__20230331_fKDEpKDIp_z2nncnzBmRWb" style="text-align: right" title="Warrants">19,257,515</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Convertible debt</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_uShares_c20240101__20240331_fKDEpKDIp_zxXq1QjbNZe3" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible debt">714,900</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--IncrementalCommonSharesAttributableToConversionOfDebtSecurities_pid_uShares_c20220701__20230331_fKDEpKDIp_zOPZGPsaF0s3" style="border-bottom: Black 1pt solid; text-align: right" title="Convertible debt">2,723,500</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Total potential dilutive securities</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 2pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--DilutiveSecurities_c20240101__20240331_fKDEpKDIp_zsHe0uQXdurb" style="border-bottom: Black 2pt solid; text-align: right" title="Total potentially dilutive securities">21,863,005</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 2pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--DilutiveSecurities_c20220701__20230331_fKDEpKDIp_zMJCuPdfJ9G7" style="border-bottom: Black 2pt solid; text-align: right" title="Total potentially dilutive securities">23,542,515</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> </table> <p style="margin-top: 0; margin-bottom: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.5in"> </td> <td style="width: 0.5in; text-align: justify"><span id="xdx_F04_z8uwCPReib17" style="font-size: 10pt">(1)</span></td> <td style="text-align: justify"><span id="xdx_F17_zfE386LVZsY8" style="font-size: 10pt">The number of shares is based on the maximum number of shares issuable on exercise or conversion of the related securities as of the period end. Such amounts have not been adjusted for the treasury stock method or weighted average outstanding calculations as required if the securities were dilutive.</span></td></tr> <tr style="vertical-align: top"> <td> </td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td> </td> <td style="text-align: justify"><span id="xdx_F08_zgw7XYu0P2Nc" style="font-size: 10pt">(2)</span></td> <td style="text-align: justify"><span id="xdx_F1B_zmfAQTknsNLd" style="font-size: 10pt">Earnout Shares are excluded as the vesting terms were not met as of the end of the reporting period.</span></td></tr> </table> <p id="xdx_8AD_z0904HxELYr5" style="margin-top: 0; margin-bottom: 0"></p> <p id="xdx_855_zwZEC6Js9if7" style="margin-top: 0; margin-bottom: 0"></p>
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_847_eus-gaap--UseOfEstimates_zpqYF51i4lci" style="margin-top: 0; margin-bottom: 0"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0; width: 100%"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">c)</span></td><td><span style="font-size: 10pt"><span id="xdx_86E_zncxrOQRZSC8">Use of Estimates</span></span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to the carrying value of long-term assets, deferred income tax assets and related valuations, liabilities related to the Earnout Shares, Private Warrants, and Contingent Consent Warrants (each, as defined below), and share-based compensation. The Company bases its estimates and assumptions on current facts, historical experience, and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between estimates and the actual results, future results of operations will be affected.</p>
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-4225000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-29435000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-10999000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-35741000	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	4058000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	29379000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	10479000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	35698000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-184000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-708000	usd
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-825000	usd
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-271000	usd
CY2024Q1	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Basic NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic	3874000	usd
CY2023Q1	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Basic NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic	28671000	usd
	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Basic NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic	9654000	usd
	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Basic NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic	35427000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	35160333	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28546379	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	33421185	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28128731	shares
CY2024Q1	niobf	Earnings Loss Per Share Basic And Diluted EarningsLossPerShareBasicAndDiluted	0.11
CY2023Q1	niobf	Earnings Loss Per Share Basic And Diluted EarningsLossPerShareBasicAndDiluted	1.00
	niobf	Earnings Loss Per Share Basic And Diluted EarningsLossPerShareBasicAndDiluted	0.29
	niobf	Earnings Loss Per Share Basic And Diluted EarningsLossPerShareBasicAndDiluted	1.26
CY2024Q1	us-gaap	Incremental Common Shares Attributable To Written Put Options IncrementalCommonSharesAttributableToWrittenPutOptions	2563000	shares
	us-gaap	Incremental Common Shares Attributable To Written Put Options IncrementalCommonSharesAttributableToWrittenPutOptions	1561500	shares
CY2024Q1	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	18585105	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	19257515	shares
CY2024Q1	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	714900	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	2723500	shares
CY2024Q1	us-gaap	Dilutive Securities DilutiveSecurities	21863005000	usd
	us-gaap	Dilutive Securities DilutiveSecurities	23542515000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-10999000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-35741000	usd
CY2024Q1	us-gaap	Investment Company Distributable Earnings Loss Accumulated Capital Loss Carryforward InvestmentCompanyDistributableEarningsLossAccumulatedCapitalLossCarryforward	8678000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-161037000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	194000	usd
CY2024Q2	us-gaap	Proceeds From Repayments Of Debt ProceedsFromRepaymentsOfDebt	6935	usd
CY2024Q1	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	4788000	usd
CY2023Q2	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	1990000	usd
CY2024Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	263000	usd
CY2023Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1324000	usd
CY2023Q2	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	101000	usd
CY2024Q1	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	48000	usd
CY2023Q2	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	48000	usd
CY2024Q1	us-gaap	Accounts Payable And Accrued Liabilities Fair Value Disclosure AccountsPayableAndAccruedLiabilitiesFairValueDisclosure	28000	usd
CY2023Q2	us-gaap	Accounts Payable And Accrued Liabilities Fair Value Disclosure AccountsPayableAndAccruedLiabilitiesFairValueDisclosure	28000	usd
CY2024Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	5127000	usd
CY2023Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	3491000	usd
CY2023Q2	us-gaap	Convertible Debt ConvertibleDebt	10561000	usd
	us-gaap	Accretion Expense Including Asset Retirement Obligations AccretionExpenseIncludingAssetRetirementObligations	4267000	usd
	niobf	Principal And Accrued Interest Converted PrincipalAndAccruedInterestConverted	13121000	usd
CY2024Q1	us-gaap	Convertible Debt ConvertibleDebt	1707000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	43000	usd
CY2024Q1	us-gaap	Convertible Subordinated Debt ConvertibleSubordinatedDebt	1750000	usd
CY2023Q3	us-gaap	Proceeds From Other Equity ProceedsFromOtherEquity	962000	usd
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	5.45
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2563000	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.88
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	70000	shares
CY2023Q3	us-gaap	Sale Of Stock Consideration Received Per Transaction SaleOfStockConsiderationReceivedPerTransaction	259000	usd
CY2023Q3	us-gaap	Stock Issued1 StockIssued1	271000	usd
CY2023Q3	us-gaap	Nonmonetary Transaction Gain Loss Recognized On Transfer NonmonetaryTransactionGainLossRecognizedOnTransfer	12000	usd
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	75000	shares
CY2023Q3	us-gaap	Sale Of Stock Consideration Received Per Transaction SaleOfStockConsiderationReceivedPerTransaction	273000	usd
CY2023Q3	us-gaap	Stock Issued1 StockIssued1	314000	usd
CY2023Q3	us-gaap	Nonmonetary Transaction Gain Loss Recognized On Transfer NonmonetaryTransactionGainLossRecognizedOnTransfer	41000	usd
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	75000	shares
CY2023Q4	us-gaap	Sale Of Stock Consideration Received Per Transaction SaleOfStockConsiderationReceivedPerTransaction	234000	usd
CY2023Q4	us-gaap	Stock Issued1 StockIssued1	244000	usd
CY2023Q4	us-gaap	Nonmonetary Transaction Gain Loss Recognized On Transfer NonmonetaryTransactionGainLossRecognizedOnTransfer	10000	usd
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	75000	shares
CY2024Q1	us-gaap	Sale Of Stock Consideration Received Per Transaction SaleOfStockConsiderationReceivedPerTransaction	170000	usd
CY2024Q1	us-gaap	Stock Issued1 StockIssued1	174000	usd
CY2024Q1	us-gaap	Nonmonetary Transaction Gain Loss Recognized On Transfer NonmonetaryTransactionGainLossRecognizedOnTransfer	4000	usd
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	82500	shares
CY2024Q1	us-gaap	Sale Of Stock Consideration Received Per Transaction SaleOfStockConsiderationReceivedPerTransaction	210000	usd
CY2024Q1	us-gaap	Stock Issued1 StockIssued1	218000	usd
CY2024Q1	us-gaap	Nonmonetary Transaction Gain Loss Recognized On Transfer NonmonetaryTransactionGainLossRecognizedOnTransfer	8000	usd
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	85000	shares
CY2024Q1	us-gaap	Sale Of Stock Consideration Received Per Transaction SaleOfStockConsiderationReceivedPerTransaction	226000	usd
CY2024Q1	us-gaap	Stock Issued1 StockIssued1	230000	usd
CY2024Q1	us-gaap	Nonmonetary Transaction Gain Loss Recognized On Transfer NonmonetaryTransactionGainLossRecognizedOnTransfer	4000	usd
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1541500	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	7.19
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1625000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.99
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	7800	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	3.95
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	595700	shares
CY2024Q1	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	2563000	shares
CY2024Q1	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	2563000	shares
CY2023Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	18816304	shares
CY2023Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	10.98
	niobf	Class Of Warrant Or Right Granted ClassOfWarrantOrRightGranted	-663432	shares
	niobf	Class Of Warrant Or Right Exercise Price Granted ClassOfWarrantOrRightExercisePriceGranted	3.94
	niobf	Class Of Warrant Or Right Expired ClassOfWarrantOrRightExpired	894631	shares
	niobf	Class Of Warrant Or Right Exercise Price Expired ClassOfWarrantOrRightExercisePriceExpired	8.94
CY2024Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	18585105	shares
CY2024Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	10.82
CY2024Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	18585105	shares
	us-gaap	Business Combination Contingent Consideration Arrangements Description BusinessCombinationContingentConsiderationArrangementsDescription	As consideration for entering into the previously publicly disclosed Waiver and Consent Agreement, dated September 25, 2022 (the “Lind Consent”), between the Company and Lind Global Asset Management III, LLC (“Lind”), Lind received, amongst other things, the right to receive additional Warrants (the “Contingent Consent Warrants”) if on September 17, 2024, the closing trading price of the Common Shares on the TSX or such other stock exchange on which such shares may then be listed, is less than C$10.00, subject to adjustments. The number of Contingent Consent Warrants to be issued, if any, is based on the Canadian dollar equivalent (based on the then current Canadian to U.S. dollar exchange rate as reported by Bloomberg, L.P.) of $5,000 divided by the five-day volume weighted average price of the Common Shares on the date of issuance.
CY2023Q1	us-gaap	Variable Lease Cost VariableLeaseCost	3000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	10000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	9000	usd
CY2024Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	2000	usd
CY2024Q1	us-gaap	Exploration Expense ExplorationExpense	489000	usd
CY2023Q1	us-gaap	Exploration Expense ExplorationExpense	1410000	usd
	us-gaap	Exploration Expense ExplorationExpense	2417000	usd
	us-gaap	Exploration Expense ExplorationExpense	4015000	usd
CY2024Q1	niobf	Fixed Rent Expense FixedRentExpense	23000	usd
CY2023Q1	niobf	Fixed Rent Expense FixedRentExpense	15000	usd
	niobf	Fixed Rent Expense FixedRentExpense	68000	usd
	niobf	Fixed Rent Expense FixedRentExpense	60000	usd
CY2024Q1	us-gaap	Variable Lease Cost VariableLeaseCost	3000	usd
CY2023Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	3000	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	7000	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	7000	usd
CY2024Q1	us-gaap	Sublease Income SubleaseIncome	7000	usd
CY2023Q1	us-gaap	Sublease Income SubleaseIncome	6000	usd
	us-gaap	Sublease Income SubleaseIncome	23000	usd
	us-gaap	Sublease Income SubleaseIncome	24000	usd
CY2024Q1	us-gaap	Lease Cost LeaseCost	21000	usd
CY2023Q1	us-gaap	Lease Cost LeaseCost	15000	usd
	us-gaap	Lease Cost LeaseCost	62000	usd
	us-gaap	Lease Cost LeaseCost	52000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	268000	usd
CY2024Q1	niobf	Less Amount Of Payments Representing Interest LessAmountOfPaymentsRepresentingInterest	-53000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	215000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	95000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	120000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	194000	usd
CY2024Q1	niobf	Available For Sale Securities Equity Securities Other AvailableForSaleSecuritiesEquitySecuritiesOther	7000	usd
CY2024Q1	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	201000	usd
CY2024Q1	us-gaap	Other Liabilities Fair Value Disclosure OtherLiabilitiesFairValueDisclosure	6667000	usd
CY2024Q1	us-gaap	Warrants Not Settleable In Cash Fair Value Disclosure WarrantsNotSettleableInCashFairValueDisclosure	4409000	usd
CY2024Q1	us-gaap	Financial Liabilities Fair Value Disclosure FinancialLiabilitiesFairValueDisclosure	11076000	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	2341000	usd
CY2023Q2	niobf	Available For Sale Securities Equity Securities Other AvailableForSaleSecuritiesEquitySecuritiesOther	9000	usd
CY2023Q2	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	2350000	usd
CY2023Q2	us-gaap	Other Liabilities Fair Value Disclosure OtherLiabilitiesFairValueDisclosure	10521000	usd
CY2023Q2	us-gaap	Warrants Not Settleable In Cash Fair Value Disclosure WarrantsNotSettleableInCashFairValueDisclosure	4989000	usd
CY2023Q2	us-gaap	Financial Liabilities Fair Value Disclosure FinancialLiabilitiesFairValueDisclosure	15510000	usd

Files In Submission

Name	View Source	Status
0001539497-24-000937-index-headers.html	Edgar Link	pending
0001539497-24-000937-index.html	Edgar Link	pending
0001539497-24-000937.txt	Edgar Link	pending
0001539497-24-000937-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
n2574_x208-10q.htm	Edgar Link	pending
n2574_x208-img001.jpg	Edgar Link	pending
n2574_x208ex31-1.htm	Edgar Link	pending
n2574_x208ex31-2.htm	Edgar Link	pending
n2574_x208ex32-1.htm	Edgar Link	pending
n2574_x208ex32-2.htm	Edgar Link	pending
niobf-20240331.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
niobf-20240331_lab.xml	Edgar Link	unprocessable
niobf-20240331_pre.xml	Edgar Link	unprocessable
n2574_x208-10q_htm.xml	Edgar Link	completed
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
niobf-20240331_cal.xml	Edgar Link	unprocessable
niobf-20240331_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NB
NIOCORP DEVELOPMENTS LTD Stock $nb

2024 Q2 Form 10-Q Financial Statement

#000153949724000937 Filed on May 02, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NB NIOCORP DEVELOPMENTS LTD Stock $nb

2024 Q2 Form 10-Q Financial Statement

#000153949724000937 Filed on May 02, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NB
NIOCORP DEVELOPMENTS LTD Stock $nb